Ensign Peak Advisors’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $529K | Sell |
|
|||||
2024
Q4 | $1.87M | Hold |
|
|||||
2024
Q3 | $1.7M | Hold |
|
|||||
2024
Q2 | $1.48M | Buy |
|
|||||
2024
Q1 | $3.39M | Buy |
|
|||||
2022
Q2 | – | Sell |
|
|||||
2022
Q1 | $309K | Hold |
|
|||||
2021
Q4 | $404K | Buy |
|
|||||
2021
Q3 | $151K | Hold |
|
|||||
2021
Q2 | $186K | Hold |
|
|||||
2021
Q1 | $246K | Sell |
|
|||||
2020
Q4 | $193K | Sell |
|
|||||
2020
Q3 | $272K | Buy |
|
|||||
2020
Q2 | $57K | Hold |
|
|||||
2020
Q1 | $61K | Sell |
|
|||||
2019
Q4 | $131K | Buy |
|